Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aspira Women's Health Inc AWH

Healthcare Medical Devices
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their... see more

Recent & Breaking News (NDAQ:AWH)

Aspira Women's Health Reports First Quarter 2024 Financial Results

GlobeNewswire May 15, 2024

UPDATE -- Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15

GlobeNewswire May 8, 2024

Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15

GlobeNewswire May 8, 2024

Aspira Women's Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts

GlobeNewswire May 7, 2024

Aspira Women's Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch

GlobeNewswire May 2, 2024

Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California

GlobeNewswire April 9, 2024

Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 28, 2024

Aspira Women's Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call

GlobeNewswire March 25, 2024

Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference

GlobeNewswire March 21, 2024

Aspira Women's Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President

GlobeNewswire March 18, 2024

Aspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024

GlobeNewswire March 11, 2024

Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

GlobeNewswire February 22, 2024

Aspira Women's Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)

GlobeNewswire February 12, 2024

Aspira Women's Health Announces OvaSuite(SM) Distribution Agreement in the Philippines

GlobeNewswire February 6, 2024

Aspira Women's Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire January 25, 2024

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

GlobeNewswire January 25, 2024

Aspira Women's Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024

GlobeNewswire December 19, 2023

Aspira Women's Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

GlobeNewswire December 14, 2023

Aspira Women's Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis

GlobeNewswire December 6, 2023

Aspira Women's Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)

GlobeNewswire November 28, 2023